Advertisement
Survey Series
Institutions
For Advertisers
|
|
||||
|
Concern over BRCA2 patent
Email: Grit Kienzlen - grit.kienzlen@web.de News from The Scientist 2005, 6(1):20050516-01
|
||||
|
|
||||
|
Some Jewish women in Europe could face discrimination in access to breast cancer diagnosis as a result of changes made to a patent for the gene BRCA2, owned by Utah-based firm Myriad Genetics, geneticists said at a meeting this week. They said that the changes could mean that women seeking testing would have to disclose whether they were Ashkenazi Jews, and might preclude testing in countries without testing licenses.
|
|
|||||||||
|
|||||||||
|
